Some studies indicate that specific gene variations in GSTM-1 and NAT-2, which are involved in detoxifying carcinogens, could potentially increase the susceptibility of certain individuals to bladder cancer [41]. The gene discussed is NAT2; the disease is urinary bladder cancer.